EW

Edwards Lifesci

NYSE

Real-time Quotes | Nasdaq Last Sale

81.72

-0.16

-0.20%

Pre Market: 82.00 +0.28 +0.34% 08:20 03/08 EST

OPEN

82.29

PREV CLOSE

81.88

HIGH

82.49

LOW

78.86

VOLUME

TURNOVER

52 WEEK HIGH

92.08

52 WEEK LOW

51.51

MARKET CAP

51.04B

P/E (TTM)

63.32

How to Identify the Opportunity and Potential Pitfalls in Edwards Lifesciences $EW

Mar 07, 2021 (Stock Traders Daily via COMTEX) -- This Edwards Lifesciences (NYSE: EW) report helps investors and traders identify both opportunity, and...

Stock Traders Daily · 17h ago

Global Central Venous Catheters Market 2020 Key Players, Comprehensive Research, SWOT Analysis and Forecast by 2025

CDN Newswire · 17h ago

At CAGR of 6.6%, Vascular Access Device Market Top Key Players, Industry Share, Size, Trends and Forecast to 2025

AmericaNewsHour · 18h ago

Global Nitinol-based Medical Device Market 2020 Sales Channels, Technology and Production Analysis, Business Growth by 2025

Mar 07, 2021 (CDN Newswire via Comtex) -- As per a new research report titled Global Nitinol-based Medical Device Market 2020 by Manufacturers, Regions, Type...

CDN Newswire · 22h ago

Global Sutureless Aortic Valve market Size, Share, Value, and Competitive Landscape 2026

Heraldkeepers · 1d ago

Edwards Lifesciences Corp. stock falls Friday, underperforms market

Shares of Edwards Lifesciences Corp. slipped 0.20% to $81.72 Friday, on what proved to be an all-around favorable trading session for the stock market, with...

marketwatch.com · 2d ago

Vascular Access Device Market Potential Growth, Share, Demand and Analysis of Key Players, Research Forecasts To 2027

Mar 05, 2021 (Market Insight Reports) -- Selbyville, Delaware, This Global Vascular Access Device Market report studies the industry based on one or more...

Market Insight Reports · 2d ago

Japan Minimally Invasive Surgical Instruments Market will experience a noticeable growth during the forecast period 2019-2025: Orion Market Reports

Mar 05, 2021 (Market Insight Reports) -- Japan minimally invasive surgical (MIS) instruments market is expected to grow at a CAGR of around 8.2% during the...

Market Insight Reports · 3d ago

Forecast

Actual (USD)

Estimate (USD)

Income StatementMore

Net Income (USD)

YoY (%)

Balance SheetMore

Total Assets (USD)

Total Liabilities (USD)

Debt to Asset (%)

Cash FlowMore

Operating (USD)

YoY (%)

Learn about the latest financial forecast of EW. Analyze the recent business situations of Edwards Lifesci through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.

Analyst Rating

Based on 24 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average EW stock price target is 94.25 with a high estimate of 111.00 and a low estimate of 71.00.

EPS

Institutional Holdings

Institutions: 1.53K

Institutional Holdings: 532.12M

% Owned: 85.21%

Shares Outstanding: 624.52M

TypeInstitutionsShares

Increased

391

20.44M

New

219

3.05M

Decreased

385

26.85M

Sold Out

Performance
Asset Allocation
Dividend History

No Data

Industry

Advanced Medical Equipment & Technology

+1.35%

Healthcare Equipment & Supplies

+2.13%

Key Executives

Chairman/Director/Chief Executive Officer

Michael Mussallem

Chief Financial Officer/Vice President

Scott Ullem

Corporate Executive

Jean-Luc Lemercier

Vice President

Donald Bobo

Vice President

Daveen Chopra

Vice President

Catherine Szyman

Vice President

Huimin Wang

Vice President

Larry Wood

Lead Director/Independent Director

Martha Marsh

Director

Paul LaViolette

Director

Ramona Sequeira

Independent Director

Leslie Heisz

Independent Director

Kieran Gallahue

Independent Director

William Link

Independent Director

Steven Loranger

Independent Director

Heisz Stone

Independent Director

Nicholas Valeriani

No Data

All
Financials
Insiders

About EW

Edwards Lifesciences Corporation is a manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. The Company is engaged in patient-focused innovations for structural heart disease and critical care monitoring. Its segments include United States, Europe, Japan and Rest of World. Its products are categorized into three areas: Transcatheter Heart Valve Therapy, Surgical Heart Valve Therapy and Critical Care. It also develops hemodynamic monitoring systems that are used to measure a patient's cardiovascular function in the hospital setting. It is developing products, such as the Edwards SAPIEN 3 Ultra System and Edwards SAPIEN XT transcatheter heart valve, among others. Its Transcatheter Heart Valve Therapy and Surgical Heart Valve Therapy products are manufactured in the United States, Singapore and Switzerland. Critical Care products are manufactured in its facilities located in Puerto Rico and the Dominican Republic.

Webull offers kinds of Edwards Lifesciences Corp stock information, including NYSE:EW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EW stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading EW stock methods without spending real money on the virtual paper trading platform.